Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19
Authors:
Open Access
- 15 May 2024
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 16 (5) , 2113-2122
Abstract
Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19Keywords
This publication has 38 references indexed in Scilit:
- Mesenchymal stem cell therapy for COVID-19 infectionInflammopharmacology, 2023
- Adipose tissue-derived mesenchymal stromal cells attenuate acute lung injury induced by trauma and haemorrhagic shockImmunobiology, 2023
- National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance dataThe Lancet Public Health, 2023
- Multi-omic profiling reveals early immunological indicators for identifying COVID-19 ProgressorsClinical Immunology, 2023
- The fate of adipose tissue and adipose-derived stem cells in allograftCell and tissue research, 2023
- The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infectionJournal of Medical Virology, 2023
- Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem CellsStem Cell Reviews and Reports, 2023
- Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infectionImmunity, Inflammation and Disease, 2022
- Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019Cytotherapy, 2022
- Cytokine profile and disease severity in patients with COVID-19Cytokine, 2021